CCP110

Across TCGA pan-cancer cohorts, CCP110 Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated CCP110 data layer compared with 25 for mass-spec protein and 7 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CCP110 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated CCP110 expression acts as an unfavorable survival marker, although some lineages such as UCEC and SKCM show a favorable association.

UCEC, KICH, and STAD are the cancer types where CCP110 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	1.000	0.616	.002	36	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
STAD	OS	Median	All	0.199	0.730	.002	12	view →
COAD	OS	Median	All	0.176	0.673	.038	4	view →
SCLC	OS	Median	II,III,IV	0.152	0.777	.038	3	view →
SKCM	DFS	Median	II,III,IV	0.921	0.668	.039	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

CCP110–UCEC (DFS)

Open the UCEC breakdown →